Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2022 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENDO INTL PLC | 8 | Q4 2015 | 7.9% |
SABRE CORP | 8 | Q1 2016 | 8.8% |
PLATFORM SPECIALTY PRODS COR | 8 | Q4 2015 | 6.5% |
FIDELITY NATIONAL FINANCIAL | 7 | Q1 2016 | 6.8% |
LIBERTY INTERACTIVE CORP | 7 | Q3 2015 | 8.4% |
ATENTO S A | 7 | Q3 2016 | 6.8% |
VALEANT PHARMACEUTICALS INTL | 6 | Q4 2015 | 11.5% |
CONSTELLIUM NV | 6 | Q1 2015 | 7.2% |
T MOBILE US INC | 5 | Q3 2016 | 7.4% |
IMS HEALTH HLDGS INC | 5 | Q2 2016 | 7.8% |
View Tyrian Investments, L.P.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2017-02-14 |
13F-HR | 2016-11-14 |
13F-HR | 2016-08-15 |
13F-HR | 2016-05-16 |
13F-HR | 2016-02-16 |
13F-HR | 2015-11-16 |
13F-HR | 2015-08-14 |
13F-HR | 2015-05-14 |
13F-HR | 2015-02-13 |
13F-HR | 2014-11-13 |
View Tyrian Investments, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.